Cancer Vaccines

Interferon-(alpha) Demonstrates Powerful Adjuvant Effect

Published in Vaccine Weekly, May 24th, 2000

Interferon-(alpha) (IFN(alpha)) has a powerful adjuvant effect when added to cancer vaccines, researchers in Italy reported.

"Our group has recently demonstrated that the transduction of the IFN(alpha)1 gene into mouse tumor cells results in loss of tumorigenicity and development of tumor specific T-cell-mediated immunity, even when tumors resistant to the exogenous IFN treatment are used," said Maria Ferrantini and colleagues from the Istituto Superiore di Sanita and the Istituto Nazionale Tumori, Italy.

Ferrantini et al. presented data from their study at the conference Cellular Immunity and Immunotherapy of Cancer, held in Santa Fe, New Mexico. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry